Heart Failure

Clinical Trial Finder

Many patients with heart failure are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Telemedicine Technology Demonstration Project for Heart Failure

Condition:   Heart Failure
Intervention:   Other: Telemedicine
Sponsors:   Providence Health & Services;   Verizon Wireless
Recruiting - verified April 2014

ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea.

Conditions:   Heart Failure;   Obstructive Sleep Apnea;   Central Sleep Apnea
Intervention:   Other: [C11]Acetate and HED PET
Sponsor:   University of Ottawa Heart Institute
Recruiting - verified April 2014

Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction

Conditions:   Heart Failure, Diastolic;   Hypertension
Intervention:   Procedure: Renal denervation + medical therapy
Sponsor:   InCor Heart Institute
Recruiting - verified April 2014

ECG Derived Respiration for Automated Screening of Sleep Disordered Breathing in Chronic Heart Failure Patients

Conditions:   Heart Failure;   Sleep Apnea Syndromes;   Polysomnography
Intervention:   Device: ventilatory polygraphic recordings
Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
Enrolling by invitation - verified April 2014

VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients

Condition:   Heart Failure With Reduced Ejection Fraction
Intervention:   Device: Equilia® Vagal Nerve Stimulation
Sponsor:   Sorin Group
Not yet recruiting - verified April 2014

Patient-centered Care Transitions in Heart Failure: A Pragmatic Cluster Randomized Trial

Condition:   Heart Failure
Intervention:   Other: PACT-HF Model
Sponsors:   Population Health Research Institute;   Hamilton Health Sciences Corporation;   McMaster University
Not yet recruiting - verified April 2014

ASIS for Enbrel in Plaque Psoriasis

Condition:   Plaque Psoriasis.
Interventions:   Drug: Gadolinium;   Drug: Gadolinium;   Drug: Gadolinium;   Drug: Efficacy of Enbrel subcutaneously at Week 12;   Drug: Efficacy of Enbrel subcutaneously at Week 24;   Drug: Efficacy of Enbrel subcutaneously at Week 36;   Drug: Efficacy of Enbrel subdermally at Week 12;   Drug: Efficacy of Enbrel subdermally at Week 24;   Drug: Efficacy of Enbrel subdermally at Week 36;   Drug: PASI 75 n(%) subcutaneously at Week 12;   Drug: PASI 75 n(%) subcutaneously at Week 24;   Drug: PASI 75 n(%) subcutaneously at Week 36;   Drug: PASI 75 n(%) subdermally at Week 12;   Drug: PASI 75 n(%) subdermally at Week 24;   Drug: PASI 75 n(%) subdermally at Week 36;   Drug: Adverse Reactions of Enbrel subcutaneously;   Drug: Adverse Reactions of Enbrel subdermally at Week 36;   Drug: Gadolinium;   Drug: Gadolinium;   Drug: Gadolinium
Sponsor:   ASIS Corporation
Not yet recruiting - verified April 2014

Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203

Condition:   Ischemic Heart Failure
Sponsor:   Juventas Therapeutics, Inc.
Active, not recruiting - verified April 2014

Fluid Status of Outpatients With Dyspnea

Conditions:   Dyspnea,;   Acute Heart Failure Syndrome;   Pulmonary Congestion
Sponsor:   Intersection Medical, Inc.
Not yet recruiting - verified April 2014

Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects

Conditions:   Type 2 Diabetes;   Coronary Artery Disease
Sponsors:   British Cardiac Research Trust;   Royal Free Hospital NHS Foundation Trust;   North West London Hospitals NHS Trust;   Barnet and Chase Farm Hospitals NHS Trust;   Diabetes and Obesity Research Network;   Lund University;   Health Diagnostic Laboratory, Inc.
Recruiting - verified April 2014

Incisional Hernia and Adhesion-Related Bowel Obstruction

Conditions:   Colorectal Disorders;   Incisional Hernia;   Bowel Obstruction
Intervention:   Procedure: Colorectal Surgery
Sponsor:   The Cleveland Clinic
Not yet recruiting - verified April 2014

Early Aortic Valve Lipoprotein(a) Lowering Trial

Condition:   Aortic Stenosis and Lipoprotein(a) Levels
Interventions:   Drug: Extended release Niacin;   Drug: Placebo Comparator
Sponsors:   McGill University Health Center;   George Thanassoulis;   Jewish General Hospital;   Laval University;   Quebec Heart Institute
Not yet recruiting - verified April 2014

Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients

Conditions:   Metastatic Breast Cancer;   Breast Cancer
Sponsors:   Janssen Diagnostics, LLC;   The Cleveland Clinic
Not yet recruiting - verified April 2014

Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial

Conditions:   Weaning Failure;   Acute Respiratory Failure
Interventions:   Device: Optiflow (Fisher & Paykel Healthcare);   Device: Venturi mask
Sponsors:   Catholic University of the Sacred Heart;   Fisher and Paykel Healthcare
Not yet recruiting - verified April 2014

Haemodynamic Effects During Anorectal Surgery: a Comparison of the Jack -Knife and Lithotomy Position

Condition:   Anorectal Surgery Haemodynamic Changes
Intervention:   Other: Lithotomy or Prone position
Sponsor:   Lithuanian University of Health Sciences
Recruiting - verified April 2014

An Observational Pilot Study of the Effects of Traumatic Haemorrhagic Shock and Resuscitation on the Microcirculation

Condition:   Traumatic Haemorrhagic Shock
Intervention:   Device: Side Stream Dark Field Microscopy
Sponsor:   King's College Hospital NHS Trust
Not yet recruiting - verified April 2014

The Effect on Cerebral Oxygenation of Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit in Cardiac Surgery Patients

Condition:   Postoperative Cognitive Dysfunction
Intervention:   Procedure: retrograde autologous priming
Sponsor:   Amphia Hospital
Not yet recruiting - verified April 2014

Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia

Condition:   Chronic Lymphocytic Leukemia
Interventions:   Other: bendamustine;   Other: rituximab
Sponsors:   Astellas Pharma Inc;   Astellas Pharma Europe BV
Recruiting - verified April 2014

Get CardioSmart

You're Invited

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points